Medical director and founder of the Southampton, NY based Hamptons Medical Weight Loss Doctor, Dr. Sue Decotiis, announced today that her specialty medical weight loss practice has noted a surge in men and women seeking Mounjaro™ (also known by its generic sister name tirzepatide) one-weekly injectable peptide therapy for medical weight loss. Mounjaro™ is FDA-approved to treat overweight / obese individuals, as well as individuals affected by type 2 diabetes.
NEW YORK, May 18, 2023 /PRNewswire-PRWeb/ -- Medical director and founder of the Southampton, NY based Hamptons Medical Weight Loss Doctor, Dr. Sue Decotiis, announced today that her specialty medical weight loss practice has noted a surge in men and women seeking Mounjaro™ (also known by its generic sister name tirzepatide) one-weekly injectable peptide therapy for medical weight loss. Mounjaro™ is FDA-approved to treat overweight / obese individuals, as well as individuals affected by type 2 diabetes.
According to a study published in the New England Journal of Medicine: "With the use of the efficacy estimated at 40 weeks, greater reductions in the fasting serum glucose level were observed with all tirzepatide doses than with semaglutide. In addition, all the tirzepatide doses resulted in greater reductions than those with semaglutide in the patient-measured mean blood glucose levels at all seven time points", meaning patients who received weekly tirzepatide injections and practiced healthy lifestyle choices were able to lose sufficient weight compared to those who underwent semaglutide injections, alternatively.
"Our practice is one of very few New York board certified providers that offer compounded tirzepatide for medical weight loss, as the nationwide shortage of the medication has put a strain on its availability," the triple board certified medical weight loss specialist, Dr. Sue Decotiis observed. Patients with type 2 diabetes and obesity have a long history of managing their weight successfully with the help of the GLP-1 receptor agonist.
Due to widespread isolation brought on by the COVID-19 epidemic, an increase in people seeking Mounjaro® weight loss counseling can be attributed to this worldwide health crisis. Many Americans adopted a dramatic and prolonged inactive lifestyle. The National Institute of Health states that psychological distress, pre-pandemic weight status, having children at home, and the amount of time since the last bodyweight check were statistically significant predictors of pandemic weight gain.
About Us
The board certified Hamptons weight loss specialist doctor offers prescriptions for medical weight loss including Mounjaro, Ozempic, Semaglutide, and Tirzepatide. Peptide therapy for weight loss is also offered including AOD-9604 (Advanced Obesity Drug), CJC-1295 / Ipamorelin, and Tesofensine. Hamptons Medical Weight Loss Doctor, specializing in weight loss treatments, is spearheaded by the best in class triple board certified medical weight loss doctor, Sue Decotiis, MD.
Hamptons Medical Weight Loss Doctor frequently treat treats patients from South Hampton, Bridgehampton, East Hampton, Hampton Bays, Montauk, Sag Harbor, Watermill, Southampton, West Hampton, and Quogue.
Hamptons Medical Weight Loss Doctor
53 Hill Street
Suite 104
Southampton, NY 11968
(631) 910-7185
https://www.hamptonsmedicalweightlossdoctor.com
Media Contact
Erika Brown, NewYorkSEO, LLC, 9175687810, [email protected]
SOURCE Hamptons Medical Weight Loss Doctor
Share this article